Topics

Senseonics Holdings, Inc. Company Profile

02:37 EST 23rd January 2020 | BioPortfolio

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. The Eversense CGM system includes a small sensor, smart transmitter and mobile application. Based on fluorescence sensing technology, the sensor is designed to be inserted subcutaneously and communicate with the smart transmitter to wirelessly transmit glucose levels to a mobile device. After insertion, the sensor is designed to continually and accurately measure glucose levels. For more information on Senseonics, please visit www.senseonics.com.


News Articles [464 Associated News Articles listed on BioPortfolio]

Senseonics nets $23.5mm via FOPO

Senseonics Holdings Inc. (developing an implantable continuous glucose monitoring (CGM) system) netted $23.5mm through the public sale of 22.7mm common shares at $1.10. The company concurrently announ...

Senseonics announces $80mm debt financing

Senseonics Holdings Inc. (developing a continuous glucose monitoring system for diabetics) commenced an offering of $80mm aggregate principal amount of 5.25% convertible senior notes due 2025 to Solar...

Senseonics publishes positive results for Eversense CGM System

Senseonics Holdings, a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people wi...

Senseonics Holdings, Inc. Schedules Second Quarter 2019 Earnings Release and Conference Call for August 7, 2019 at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system f...

Senseonics Holdings, Inc. Schedules Third Quarter 2019 Earnings Release and Conference Call for November 12, 2019 at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitori...

Senseonics to Participate in the Raymond James Life Sciences and MedTech Conference

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monit...

Senseonics enrols diabetes patients in PROMISE Clinical Study

Senseonics Holdings, a US-based medical technology company, has completed the enrolment of patients in the Eversense PROMISE 180-day sensor Clinical Study. The company has developed and commercialised...

Senseonics Holdings (SENS) Investor Presentation - Slideshow

PubMed Articles [7 Associated PubMed Articles listed on BioPortfolio]

Serological surveillance reveals patterns of exposure to H5 and H7 influenza A viruses in European poultry.

Influenza A viruses of H5 and H7 subtype in poultry can circulate subclinically, and subsequently mutate from low to high pathogenicity with potentially devastating economic and welfare consequences. ...

Current Status of Delamanid in the Management of MDR Tuberculosis.

Delamanid is a nitro-dihydro-imidazooxazole compound which was developed by a Japanese company, Otsuka Holdings inc. and has shown in-vitro and in-vivo activity against drug resistant tuberculosis. Th...

Low-frequency electromagnetic fields as an alternative to sanitize water of drinking systems in poultry production?

Low-frequency electromagnetic fields (LF-EMF) may present an alternative to conventional sanitation methods of water supply lines in animal production. The objective of this study was to evaluate the ...

Market-based opportunities for expanding native seed resources for restoration: A case study on the Colorado Plateau.

The National Seed Strategy for Rehabilitation and Restoration aims to increase the use of native seeds in rehabilitation and restoration projects. This requires the development of a native seed supply...

sPortfolio: Stratified Visual Analysis of Stock Portfolios.

Quantitative Investment, built on the solid foundation of robust financial theories, is at the center stage in investment industry today. The essence of quantitative investment is the multi-factor mod...

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

A Feasibility Trial to Evaluate the Senseonics Continuous Glucose Monitoring System in Canada

The purpose of this clinical investigation is to evaluate the effectiveness of modified Sensor designs on the longevity (up to 180 days) of the Senseonics Continuous Glucose Monitoring (CG...

Evaluation of the Accuracy of an Implanted Glucose Sensor

The purpose of this clinical investigation is to evaluate the accuracy of the Senseonics Continuous Glucose Monitoring System (Senseonics CGM System) measurements when compared with refere...

Evaluation of the Eversense Continuous Glucose Monitoring System in Type I Diabetic Youth

The purpose of this clinical investigation is to provide pilot clinical data to direct pivotal study development for the pediatric indication of the Senseonics Continuous Glucose Monitorin...

Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease

To afford urgent access to a potential-disease modifying treatment, Dr. Diana Kerwin, in partnership with CTD Holdings, the manufacturer of Trappsol (R) Cyclo(TM), will administer the prod...

Home Use Sensor Study

The purpose of this clinical investigation is to evaluate the accuracy of the Eversense Continuous Glucose Monitoring System (Eversense System) measurements when compared with a Self-monit...

Companies [522 Associated Companies listed on BioPortfolio]

Senseonics Holdings Inc.

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to help people with diab...

Senseonics Holdings, Inc.

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of a long-term, implantable continuous glucose monitoring...

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

Sabre Holdings

Sabre Holdings connects people with the world's greatest travel possibilities by retailing travel products and providing distribution and technology solutions for the travel indus...

HealthTech Holdings, Inc.

HealthTech Holdings, Inc. is a health information technology holding-company, with portfolio companies including HMS, MEDHOST and Sentry Healthcare Services, Inc. HealthTec...

More Information about "Senseonics Holdings, Inc." on BioPortfolio

We have published hundreds of Senseonics Holdings, Inc. news stories on BioPortfolio along with dozens of Senseonics Holdings, Inc. Clinical Trials and PubMed Articles about Senseonics Holdings, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Senseonics Holdings, Inc. Companies in our database. You can also find out about relevant Senseonics Holdings, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record